The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
Open accessAbstract
Purpose: Adjuvant chemotherapy for breast cancer can have adverse effects on cognition shortly after administration. Whether chemotherapy has any long-term effects on cognition is largely unknown, yet it becomes increasingly relevant because of the widespread use of chemotherapy for early-stage breast cancer and the improved survival. We investigated whether cyclophosphamide, methotrexate, and fluorouracil (CMF) chemotherapy for breast cancer is associated with worse cognitive performance more than 20 years after treatment. Patients and Methods: This case-cohort study compared the cognitive performance of patients with breast cancer who had a history of adjuvant CMF chemotherapy treatment (six cycles; average time since treatment, 21 years; n = 196) to that of a population-based sample of women never diagnosed with cancer (n = 1,509). Participants were between 50 and 80 years of age. Exclusion criteria were ever use of adjuvant endocrine therapy, secondary malignancy, recurrence, and/or metastasis. Results: The women exposed to chemotherapy performed significantly worse than the reference group on cognitive tests of immediate (P = .015) and delayed verbal memory (P = .002), processing speed (P < .001), executive functioning (P = .013), and psychomotor speed (P = .001). They experienced fewer symptoms of depression (P < .001), yet had significantly more memory complaints on two of three measures that could not be explained by cognitive test performance. Conclusion: Survivors of breast cancer treated with adjuvant CMF chemotherapy more than 20 years ago perform worse, on average, than random population controls on neuropsychological tests. The pattern of cognitive problems is largely similar to that observed in patients shortly after cessation of chemotherapy. This study suggests that cognitive deficits following breast cancer diagnosis and subsequent CMF chemotherapy can be long lasting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Tabachnick, B. G., & Fidell, L. S. (1983) · Cited by 80,031
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
On the generalized distance in statistics
Mahalanobis, P. C. (1936) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6,068
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
On the meaning and use of kurtosis.
DeCarlo, L. T. (1997) · Psychological Methods · doi:10.1037//1082-989x.2.3.292 · Cited by 1,755
The Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Self-citationThe Purdue Pegboard: norms and studies of reliability and validity.
Tiffin, J., & Asher, E. J. (1948) · Journal of Applied Psychology · doi:10.1037/h0061266 · Cited by 1,246
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationCandidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Self-citationAhles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Self-citationAhles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0827 · Cited by 535
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010) · Cancer · doi:10.1002/cncr.25098 · Cited by 513
Jenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., Verhoeven, J. S., Christiaens, M.-R., Vandenberghe, J., Vandenbulcke, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8571 · Cited by 389
van der Elst, W., van Boxtel, M. P. J., van Breukelen, G. J. P., & Jolles, J. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390591004428 · Cited by 386
Knight, R. G., Williams, S., McGee, R., & Olaman, S. (1997) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(96)00107-6 · Cited by 374
Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007) · Cancer · doi:10.1002/cncr.22610 · Cited by 356
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., et al. (2007) · Cancer · doi:10.1002/cncr.22368 · Cited by 350
Stroop interference: Aging effects assessed with the stroop color-word test
Houx, P. J., Jolles, J., & Vreeling, F. W. (1993) · Experimental Aging Research · doi:10.1080/03610739308253934 · Cited by 350
Cognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345
Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0130 · Cited by 341
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
VAN DER ELST, W., VAN BOXTEL, M. P. J., VAN BREUKELEN, G. J. P., & JOLLES, J. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060115 · Cited by 334
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1088-4 · Cited by 331
Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm500 · Cited by 331
Self-citationCognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S. A. M., Nederveen, A. J., Boven, E., & Schagen, S. B. (2011) · Human Brain Mapping · doi:10.1002/hbm.21102 · Cited by 305
Self-citationSchagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj470 · Cited by 295
Self-citationDeprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Stock, J. V. D., Smeets, A., Christiaens, M., Leemans, A., Hecke, W. V., et al. (2011) · Human Brain Mapping · doi:10.1002/hbm.21033 · Cited by 275
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., Lavini, C., Linn, S. C., Boven, E., van Dam, F. S. A. M., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.21422 · Cited by 273
Self-citationFerguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8639 · Cited by 272
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
Jansen, C. E., Cooper, B. A., Dodd, M. J., & Miaskowski, C. A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0997-4 · Cited by 271
Vardy, J., Rourke, S., & Tannock, I. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1604 · Cited by 270
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Seigers, R., & Fardell, J. E. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.006 · Cited by 266
Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., & van Dam, F. S. A. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf241 · Cited by 262
Self-citationSEIGERS, R., SCHAGEN, S., BEERLING, W., BOOGERD, W., VANTELLINGEN, O., VANDAM, F., KOOLHAAS, J., & BUWALDA, B. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.004 · Cited by 246
Self-citationThe Rotterdam Study: 2010 objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Janssen, H. L. A., Krestin, G. P., Kuipers, E. J., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., et al. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9386-z · Cited by 244
Self-citationStewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006) · The Clinical Neuropsychologist · doi:10.1080/138540491005875 · Cited by 225
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/s1084-3612(03)00055-8 · Cited by 194
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice
WINOCUR, G., VARDY, J., BINNS, M., KERR, L., & TANNOCK, I. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.010 · Cited by 193
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
Quesnel, C., Savard, J., & Ivers, H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0114-2 · Cited by 182
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009) · Psycho-Oncology · doi:10.1002/pon.1379 · Cited by 168
Abraham, J., Haut, M. W., Morán, M. T. C., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.007 · Cited by 162
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
Stewart, A., Collins, B., MacKenzie, J., Tomiak, E. M., Verma, S., & Bielajew, C. H. (2007) · Psycho-Oncology · doi:10.1002/pon.1210 · Cited by 155
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats
Seigers, R., Schagen, S. B., Coppens, C. M., van der Most, P. J., van Dam, F. S. A. M., Koolhaas, J. M., & Buwalda, B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.025 · Cited by 154
Self-citationJansen, C. E., Dodd, M. J., Miaskowski, C. A., Dowling, G. A., & Kramer, J. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1342 · Cited by 146
Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy
Wefel, J. S., Witgert, M. E., & Meyers, C. A. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9058-x · Cited by 138
Yamada, T. H., Denburg, N. L., Beglinger, L. J., & Schultz, S. K. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.1.48 · Cited by 137
Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients
Vearncombe, K., Rolfe, M. I., Wright, M. J., Pachana, N. A., Andrew, B., & Beadle, G. F. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990567 · Cited by 136
Reid‐Arndt, S. A., Hsieh, C., & Perry, M. C. (2009) · Psycho-Oncology · doi:10.1002/pon.1581 · Cited by 132
Cognitive functioning in breast cancer survivors: A controlled comparison
Jim, H., Donovan, K. A., Small, B. J., Andrykowski, M. A., Münster, P. N., & Jacobsen, P. B. (2009) · Cancer · doi:10.1002/cncr.24192 · Cited by 131
Briones, T. L., & Woods, J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-124 · Cited by 127
Neurocognitive Changes in Cancer Survivors
Correa, D. D., & Ahles, T. A. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31818d8769 · Cited by 124
Debess, J. E., Riis, J. Ø., Engebjerg, M. C., & Ewertz, M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0756-8 · Cited by 112
Weis, J., Poppelreuter, M., & Bartsch, H. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1472 · Cited by 112
Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M. B., Cheung, Y. K. K., Fang, Y., Golden, C. R., Frosch, M. E., Habif, U., Mulligan, M. M., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0606-8 · Cited by 111
Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., Metzner, B., Thiel, E., Zander, A. R., Schulz‐Kindermann, F., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj108 · Cited by 111
Postoperative Cognitive Dysfunction in the Elderly
Ramaiah, R., & Lam, A. M. (2009) · Anesthesiology Clinics · doi:10.1016/j.anclin.2009.07.011 · Cited by 103
A Simple Multivariate Test for One-Sided Alternatives
Follmann, D. A. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476953 · Cited by 98
Mild cognitive impairment: Conceptual issues and structural and functional brain correlates
Saykin, A. J., & Wishart, H. A. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50002 · Cited by 95
Reiriz, A. B., Reolon, G. K., Preissler, T., Rosado, J. O., Henriques, J. A. P., Roesler, R., & Schwartsmann, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0138 · Cited by 83
Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994) · PubMed Central · Cited by 82
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D. C., & Bielajew, C. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390801992725 · Cited by 81
Measuring Cognitive Function With Age: The Influence of Selection by Health and Survival
Euser, S. M., Schram, M. T., Hofman, A., Westendorp, R. G. J., & Breteler, M. M. B. (2008) · Epidemiology · doi:10.1097/ede.0b013e31816a1d31 · Cited by 77
Self-citationPersistent Neurocognitive Problems After Adjuvant Chemotherapy for Breast Cancer
Kreukels, B. P. C., van Dam, F. S. A. M., Ridderinkhof, K. R., Boogerd, W. J., & Schagen, S. B. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.006 · Cited by 69
Self-citationCastellon, S. A., Silverman, D. H. S., & Ganz, P. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5342-0 · Cited by 49
Cognitive dysfunction in people with cancer
Schagen, S. B., & Vardy, J. L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70287-5 · Cited by 49
Self-citationPurdue pegboard performance of disabled and normal readers: Unimanual versus bimanual differences
Leslie, S. C., Davidson, R. J., & Batey, O. B. (1985) · Brain and Language · doi:10.1016/0093-934x(85)90140-3 · Cited by 35
Neuropsychological studies in breast cancer: in search of chemobrain
Castellon, S. A., & Ganz, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0211-2 · Cited by 28
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Self-citationCarreira, H., Williams, R., Müller, M., Harewood, R., Stanway, S., & Bhaskaran, K. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy177 · Cited by 416
Metadata
- Authors
- Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-04-01
- Volume
- 30
- Issue
- 10
- Pages
- 1080-1086
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168711831
- Cited by
- 556
- References
- 74
- FWCI
- 26.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.